EBITDA fell 12.9% and NPAT loss widened to $7.2m on 2H deterioration

The operating cash line moved the other way. Net cash from operating activities rose 13.2% to $38.4m, cash conversion (OCF/EBITDA) lifted to 81.2% from 62.5%, and gross borrowings fell 32.1% to $24.3m, leaving net debt at $15.6m (around 0.3x EBITDA).

Capital intensity stepped up materially. Capex jumped from $5.0m to $19.1m (+282.7%), lifting capex/revenue to 5.6% from 1.4%. Cash on hand fell to $8.7m from $14.9m. Segment mix also shifted: Freight revenue fell to $146.0m from $180.9m, while Contract Logistics revenue grew to $159.4m and became the largest division.

HY23 NPAT was -$1.5m, but the full-year loss reached -$7.2m, implying a second-half loss near -$5.7m. EBITDA also skewed second-half-light (HY23 was 46.3% of the full year). The implication is that exit-rate earnings are weaker than the headline annual numbers suggest, and the trajectory through 2H23 worsened rather than stabilised.

Segment results improved, but group earnings fell. Contract Logistics result rose to $34.4m from $9.9m, Freight to $9.3m from $2.9m, and Specialist swung positive. Yet group EBITDA fell $7.0m. That gap implies a sharp rise in unallocated corporate or non-trading costs, and management flags $1.7m of non-trading items plus investment in growth initiatives. The read on underlying margin is therefore obscured by group-level cost build.

Capital intensity has reset higher just as earnings are falling. Capex of $19.1m (5.6% of revenue) is almost four times FY22's $5.0m, while reported free cash flow of $35.4m is supported by a $6.5m drop in trade receivables (debtor days down to 53.5 from 60.0). If working-capital release does not repeat and capex stays elevated, future free cash flow could compress materially.

Management commentary points to organic growth, customer acquisition, base-volume building, ongoing Freight improvement, and an acquisition in the current period, but these are qualitative.

What the release does support is that FY23 was second-half-weighted to the downside on earnings: 2H23 NPAT (-$5.7m) was materially worse than 1H23 (-$1.5m). What it does not support is a clean read on FY24 run-rate, because exit margins, the cost base after growth investment, and acquisition contribution are not quantified. That gap matters because the deteriorating earnings shape is the dominant signal investors must extrapolate from.

OCF of $38.4m exceeded EBITDA of $47.3m only partially (81.2% conversion), and the reported FCF of $35.4m sits against an NPAT loss of $7.2m (FCF/NPAT of -492.8%), an indicator that cash is being generated despite an accounting loss largely because of depreciation, working-capital release, and possibly disposal proceeds netted into the FCF presentation.

Several elements look timing- or balance-sheet-driven rather than durable: receivable days fell 6.5 days releasing roughly $6.5m of working capital; gross borrowings were paid down $11.5m; and capex stepped up sharply, meaning lease- and depreciation-related cash dynamics will shift in FY24. Group earnings are also flattered or hurt by $1.7m of non-trading items and undisclosed corporate-cost movements that explain why segment results rose while group EBITDA fell. ROE moved deeper negative at -9.6% from -5.8%, consistent with the loss widening despite a marginally larger equity base.

This briefing cannot assess management's FY24 earnings trajectory, acquisition economics, or the durability of segment-level margin gains, because no forward guidance, backlog, or post-acquisition pro-forma is supplied.